61. Autoimmune hemolytic anemia
90 clinical trials,   72 drugs   (DrugBank: 23 drugs),   19 drug target genes,   147 drug target pathways

Searched query = "Autoimmune hemolytic anemia", "AIHA", "WAIHA", "Cold agglutinin disease", "CAD", "Paroxysmal cold hemoglobinuria", "MAIHA", "Evans syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01303952
(ClinicalTrials.gov)
January 201124/2/2011Therapy of Chronic Cold Agglutinin Disease With EculizumabTherapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients With Cold Agglutinin Disease Using EculizumabCold Agglutinin DiseaseDrug: EculizumabUniversity Hospital, EssenAlexion PharmaceuticalsCompleted18 YearsN/AAll13Phase 2Germany
2EUCTR2009-016966-97-DE
(EUCTR)
08/06/201008/02/2010Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized, Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients with Cold Agglutinin Disease Using Eculizumab - DECADE TrialTherapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized, Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients with Cold Agglutinin Disease Using Eculizumab - DECADE Trial Cold agglutinin disease
MedDRA version: 12.1;Level: LLT;Classification code 10009868;Term: Cold type haemolytic anaemia
Trade Name: Soliris (R)Universitätsklinikum EssenNULLNot RecruitingFemale: yes
Male: yes
Germany